530 HERMAN O. WEST DRIVE, EXTON, PA
Amended material disclosure
Is committed to providing timely and transparent communication to all stakeholders regarding the recent cyberattack on its network systems.
West Pharmaceutical Services Elects Eleven Directors at Annual Meeting
Financial Results, Reg. FD
Investor Presentation
Reports Fourth-Quarter and Full-Year 2025 Results
Reports Third-Quarter 2025 Results
News
Q1
FY 2024
Q3
Q2
FY 2023
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Additional Proxy Soliciting Materials
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Specialized Disclosure Report
S-8 POS